{
    "timestamp": "2025-07-07T18:11:01.186928",
    "filename": "chunk_066_unknown_date.md",
    "raw_entities": "\n\n```json\n{\n  \"chunk_id\": \"2024-03-02\",\n  \"entities\": [\n    {\"name\": \"Mtb\", \"type\": \"生物分子\"},\n    {\"name\": \"脂阿拉伯甘露聚糖\", \"type\": \"生物分子\"},\n    {\"name\": \"钙离子\", \"type\": \"生物分子\"},\n    {\"name\": \"溶酶体\", \"type\": \"生物分子\"},\n    {\"name\": \"单核苷酸多态性\", \"type\": \"生物分子\"},\n    {\"name\": \"rpoB基因\", \"type\": \"生物分子\"},\n    {\"name\": \"TGS1基因\", \"type\": \"生物分子\"},\n    {\"name\": \"InhA\", \"type\": \"生物分子\"},\n    {\"name\": \"RNA聚合酶β\", \"type\": \"生物分子\"},\n    {\"name\": \"KatG\", \"type\": \"生物分子\"},\n    {\"name\": \"异烟肼\", \"type\": \"生物分子\"},\n    {\"name\": \"异烟碱\", \"type\": \"生物分子\"},\n    {\"name\": \"NAD\", \"type\": \"生物分子\"},\n    {\"name\": \"利福平\", \"type\": \"生物分子\"},\n    {\"name\": \"外排泵\", \"type\": \"生物分子\"},\n    {\"name\": \"sRNA\", \"type\": \"生物分子\"},\n    {\"name\": \"WhiB转录因子\", \"type\": \"生物分子\"},\n    {\"name\": \"Sigma\", \"type\": \"生物分子\"},\n    {\"name\": \"脂肪酸合成\", \"type\": \"生物技术\"},\n    {\"name\": \"细胞壁增厚\", \"type\": \"生物技术\"},\n    {\"name\": \"代谢转化\", \"type\": \"生物技术\"},\n    {\"name\": \"代谢网络\", \"type\": \"生物技术\"},\n    {\"name\": \"转录网络\", \"type\": \"生物技术\"},\n    {\"name\": \"抗结核药物\", \"type\": \"生物医学概念\"},\n    {\"name\": \"多重耐药\", \"type\": \"生物医学概念\"},\n    {\"name\": \"先天性耐药\", \"type\": \"生物医学概念\"},\n    {\"name\": \"获得性耐药\", \"type\": \"生物医学概念\"},\n    {\"name\": \"非特异性固有耐药\", \"type\": \"生物医学概念\"}\n  ]\n}\n```",
    "raw_relations": "\n\n```json\n{\n  \"chunk_id\": \"2024-03-02\",\n  \"relations\": [\n    {\"head\": \"吞噬Mtb\", \"type\": \"调控\", \"tail\": \"巨噬细胞内吞作用的酸度降低\"},\n    {\"head\": \"脂阿拉伯甘露聚糖\", \"type\": \"调控\", \"tail\": \"钙离子信号\"},\n    {\"head\": \"Mtb\", \"type\": \"使用\", \"tail\": \"抑制吞噬体与溶酶体的结合\"},\n    {\"head\": \"非特异性固有耐药\", \"type\": \"属于\", \"tail\": \"耐药机制\"},\n    {\"head\": \"获得性耐药\", \"type\": \"属于\", \"tail\": \"耐药机制\"},\n    {\"head\": \"复杂的代谢网络\", \"type\": \"调控\", \"tail\": \"Mtb先天性耐药\"},\n    {\"head\": \"WhiB转录因子\", \"type\": \"调控\", \"tail\": \"耐药性\"},\n    {\"head\": \"Sigma\", \"type\": \"调控\", \"tail\": \"耐药性\"},\n    {\"head\": \"毒素-抗毒素系统\", \"type\": \"属于\", \"tail\": \"转录后调控\"},\n    {\"head\": \"sRNA的变化\", \"type\": \"导致\", \"tail\": \"Mtb先天性耐药性\"},\n    {\"head\": \"抗结核药物\", \"type\": \"导致\", \"tail\": \"疗效下降\"},\n    {\"head\": \"TGS1基因\", \"type\": \"参与\", \"tail\": \"脂肪酸合成\"},\n    {\"head\": \"脂肪酸合成\", \"type\": \"属于\", \"tail\": \"代谢转化\"},\n    {\"head\": \"外排泵的增加\", \"type\": \"导致\", \"tail\": \"多重耐药\"},\n    {\"head\": \"细胞壁增厚\", \"type\": \"属于\", \"tail\": \"药物屏障\"},\n    {\"head\": \"转录网络\", \"type\": \"被破译\", \"tail\": \"耐药 Mtb 菌株\"},\n    {\"head\": \"利福平\", \"type\": \"属于\", \"tail\": \"一线药物\"},\n    {\"head\": \"利福平\", \"type\": \"作用于\", \"tail\": \"RNA聚合酶β\"},\n    {\"head\": \"rpoB基因\", \"type\": \"编码\", \"tail\": \"RNA聚合酶β\"},\n    {\"head\": \"异烟肼\", \"type\": \"被激活\", \"tail\": \"KatG\"},\n    {\"head\": \"KatG\", \"type\": \"参与\", \"tail\": \"代谢转化\"},\n    {\"head\": \"异烟肼\", \"type\": \"代谢成\", \"tail\": \"异烟碱-NAD\"},\n    {\"head\": \"NAD\", \"type\": \"参与\", \"tail\": \"异烟碱-NAD合成\"},\n    {\"head\": \"InhA\", \"type\": \"被抑制\", \"tail\": \"异烟碱-NAD\"},\n    {\"head\": \"InhA\", \"type\": \"参与\", \"tail\": \"细胞壁完整性\"},\n    {\"head\": \"单核苷酸多态性\", \"type\": \"参与\", \"tail\": \"获得性耐药\"},\n    {\"head\": \"rpoB基因\", \"type\": \"参与\", \"tail\": \"获得性耐药\"},\n    {\"head\": \"代谢转化\", \"type\": \"属于\", \"tail\": \"Mtb的固有耐药\"}\n  ]\n}\n```"
}